BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 36508964)

  • 1. Japanese cancer screening programs during the COVID-19 pandemic: Changes in participation between 2017-2020.
    Machii R; Takahashi H
    Cancer Epidemiol; 2023 Feb; 82():102313. PubMed ID: 36508964
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cancer screening in Japan 2 years after the COVID-19 pandemic: Changes in participation, 2017-2021.
    Machii R; Takahashi H; Miyazawa J; Nakayama T
    Prev Med Rep; 2024 Mar; 39():102649. PubMed ID: 38375089
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of COVID-19 on screening for colorectal, gastric, breast, and cervical cancer in Korea.
    Park H; Seo SH; Park JH; Yoo SH; Keam B; Shin A
    Epidemiol Health; 2022; 44():e2022053. PubMed ID: 35760396
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A national quality improvement study identifying and addressing cancer screening deficits due to the COVID-19 pandemic.
    Joung RH; Nelson H; Mullett TW; Kurtzman SH; Shafir S; Harris JB; Yao KA; Brajcich BC; Bilimoria KY; Cance WG
    Cancer; 2022 Jun; 128(11):2119-2125. PubMed ID: 35307815
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cancer Screening Disparities Before and After the COVID-19 Pandemic.
    Lofters AK; Wu F; Frymire E; Kiran T; Vahabi M; Green ME; Glazier RH
    JAMA Netw Open; 2023 Nov; 6(11):e2343796. PubMed ID: 37983033
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modeling Strategies to Optimize Cancer Screening in USPSTF Guideline-Noncompliant Women.
    Taksler GB; Peterse EFP; Willems I; Ten Haaf K; Jansen EEL; de Kok IMCM; van Ravesteyn NT; de Koning HJ; Lansdorp-Vogelaar I
    JAMA Oncol; 2021 Jun; 7(6):885-894. PubMed ID: 33914025
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cancer screening participation in schizophrenic outpatients and the influence of their functional disability on the screening rate: A cross-sectional study in Japan.
    Fujiwara M; Inagaki M; Nakaya N; Fujimori M; Higuchi Y; Hayashibara C; So R; Kakeda K; Kodama M; Uchitomi Y; Yamada N
    Psychiatry Clin Neurosci; 2017 Dec; 71(12):813-825. PubMed ID: 28875514
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of Cancer Screening Deficit in the United States With the COVID-19 Pandemic.
    Chen RC; Haynes K; Du S; Barron J; Katz AJ
    JAMA Oncol; 2021 Jun; 7(6):878-884. PubMed ID: 33914015
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A population-based survey of self-reported delays in breast, cervical, colorectal and lung cancer screening.
    Gunn CM; Berrian K; Weiss JE; Tosteson AAN; Hasson RM; Di Florio-Alexander R; Peacock JL; Rees JR
    Prev Med; 2023 Oct; 175():107649. PubMed ID: 37517458
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Oncological organized screening programmes in the COVID-19 era: an Italian survey on accrued delays, reboot velocity, and diagnostic delay estimates].
    Mantellini P; Battisti F; Armaroli P; Giubilato P; Ventura L; Zorzi M; Battagello J; Sassoli de Bianchi P; Senore C; Zappa M
    Epidemiol Prev; 2020; 44(5-6 Suppl 2):344-352. PubMed ID: 33412828
    [TBL] [Abstract][Full Text] [Related]  

  • 11. COVID-19 and inequities in colorectal and cervical cancer screening and diagnosis in Washington State.
    Amram O; Amiri S; Robison J; Pflugeisen CM; Monsivais P
    Cancer Med; 2022 Aug; 11(15):2990-2998. PubMed ID: 35304835
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes in cancer screening process in primary care during the covid-19 pandemic.
    Atadağ YB; Türkmen AT; Öksüz A; Keten HS; Aydin MR
    Saudi Med J; 2023 Jun; 44(6):621-624. PubMed ID: 37343993
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Le disuguaglianze di accesso ai programmi di screening dei tumori della mammella, del colon retto e della cervice uterina sono aumentate durante il periodo pandemico. Risultati di un health equity audit condotto dall'Agenzia di Tutela della Salute d.
    Girardi D; Vecchio R; Tanious M; Cacitti S; Ancarani C; Dalle Carbonare S; Perotti P; Bonafede C; Cavallo R; Gentile L; Parrini A; Lucente EM; Carlesso A; Cadum E; Cecconami L; Odone A; Deandrea S
    Epidemiol Prev; 2024; 48(2):130-139. PubMed ID: 38770730
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cancer screening uptake: association with individual characteristics, geographic distribution, and time trends in Italy.
    Carrozzi G; Sampaolo L; Bolognesi L; Sardonini L; Bertozzi N; Giorgi Rossi P; Zappa M; Baldissera S; Campostrini S; Ferrante G; Masocco M; Minardi V; D'Argenzio A; Moghadam PF; Quarchioni E; Ramigni M; Trinito MO; Salmaso S;
    Epidemiol Prev; 2015; 39(3 Suppl 1):9-18. PubMed ID: 26405772
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of COVID-19 pandemic on breast and cervical cancer screening in Denmark: A register-based study.
    Nonboe MH; Napolitano G; Schroll JB; Vejborg I; Waldstrøm M; Lynge E
    Elife; 2023 Mar; 12():. PubMed ID: 36943035
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Geographic Examination of COVID-19 Test Percent Positivity and Proportional Change in Cancer Screening Volume, National Breast and Cervical Cancer Early Detection Program.
    Bermudez Y; Scott LC; Beckman M; DeGroff A; Kenney K; Sun J; Rockwell T; Helsel W; Kammerer W; Sheu A; Miller J; Richardson LC
    Prev Chronic Dis; 2022 Sep; 19():E59. PubMed ID: 36108291
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Temporal Trend in Uptake of the National General Health Checkups and Cancer Screening Program among Korean Women with Breast Cancer.
    Tran TXM; Kim S; Cha C; Park B
    Cancer Res Treat; 2024 Apr; 56(2):522-530. PubMed ID: 37905311
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of the COVID-19 pandemic on population-based cancer screening, a nationwide retrospective study in Taiwan.
    Su CH; Hsu PS; Lin CS
    BMC Health Serv Res; 2023 Aug; 23(1):878. PubMed ID: 37605162
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in Cancer Screening in the US During the COVID-19 Pandemic.
    Fedewa SA; Star J; Bandi P; Minihan A; Han X; Yabroff KR; Jemal A
    JAMA Netw Open; 2022 Jun; 5(6):e2215490. PubMed ID: 35657622
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in cancer screening before and during COVID-19: findings from the Korean National Cancer Screening Survey 2019 and 2020.
    Trinh TTK; Lee YY; Suh M; Jun JK; Choi KS
    Epidemiol Health; 2022; 44():e2022051. PubMed ID: 35638224
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.